LakeShore Biopharma Co., Ltd. financial data

Symbol
LSB, LSBPW on Nasdaq
Industry
Pharmaceutical Preparations
Location
Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, China
State of incorporation
Cayman Islands
Fiscal year end
March 31
Former names
YS Biopharma Co., Ltd. (to 5/24/2024), YishengBio Co., Ltd (to 2/21/2023)
Latest financial report
20-F - Q1 2024 - Aug 15, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 190M shares +104%
Common Stock, Shares, Outstanding 190M shares +104%
Common Stock, Value, Issued 3.68K USD +106%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.9M USD
Accounts Receivable, after Allowance for Credit Loss, Current 62.6M USD -7.1%
Inventory, Net 28.7M USD +6.28%
Other Assets, Current 131K USD
Assets, Current 127M USD -15.6%
Deferred Income Tax Assets, Net 3.33M USD +1101%
Property, Plant and Equipment, Net 66.7M USD -19.8%
Operating Lease, Right-of-Use Asset 1.03M USD -36.7%
Intangible Assets, Net (Excluding Goodwill) 10M USD -11.6%
Other Assets, Noncurrent 4.84M USD +59%
Assets 213M USD -14.8%
Accounts Payable, Current 9.55M USD -18.4%
Employee-related Liabilities, Current 8.36M USD +4.06%
Liabilities, Current 113M USD +17.9%
Operating Lease, Liability, Noncurrent 251K USD -72.8%
Liabilities 131M USD -9.35%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8.2M USD -3.56%
Retained Earnings (Accumulated Deficit) -325M USD -19.3%
Stockholders' Equity Attributable to Parent 82.5M USD -22.2%
Liabilities and Equity 213M USD -14.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 9.95B shares 0%
Common Stock, Shares, Issued 190M shares +104%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 34.7M USD -33.4%
Deferred Tax Assets, Valuation Allowance 11.4M USD +99.8%
Deferred Tax Assets, Gross 3.77M USD
Operating Lease, Liability 978K USD -39.5%
Lessee, Operating Lease, Liability, to be Paid 1.01M USD -40.6%
Property, Plant and Equipment, Gross 111M USD -2.09%
Operating Lease, Liability, Current 727K USD +5.06%
Lessee, Operating Lease, Liability, to be Paid, Year Two 256K USD -65.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 759K USD +0.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 36.6K USD -60.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 222K USD
Deferred Tax Assets, Operating Loss Carryforwards 11.4M USD +99.8%
Additional Paid in Capital 387M USD
Deferred Tax Assets, Net of Valuation Allowance 842K USD